Bristol Myers Squibb plans to lay off an additional 206 employees in New Jersey, according to a new filing under New Jersey’s Worker Adjustment and Retraining Notification (WARN) Act.
The latest notice, filed in April, shows layoffs scheduled to take place in phases between July 16 and Dec. 31, 2026.
The cuts add to a series of previously announced layoffs including 247 that were slated to be laid off in a WARN filing from Feb. 2026 and more than 500 positions were already slated for elimination beginning in 2025 and continuing into early 2026.
With the newly filed notice, the total number of planned job reductions tied to recent WARN filings totals close to 1,000 positions across 2025 and 2026.
Bristol Myers Squibb has not publicly commented on the latest round of layoffs. As with prior notices, the reductions were disclosed through required state filings rather than company announcements.
Ongoing restructuring effort
The continued layoffs align with a broader company-wide initiative aimed at reducing costs.
In recent earnings reports, Bristol Myers Squibb outlined plans to achieve $2 billion in savings by the end of 2027 through organizational restructuring and operational streamlining. The company has cited pressures including declining revenue tied to generic drug competition and changes to federal drug pricing.
The company operates two major facilities in Lawrence Township, including its Route 206 campus, which houses corporate headquarters and research functions, and a Princeton Pike site focused on commercial and product development operations.
The WARN notices do not specify which positions or departments are affected.
Layoffs extend into late 2026
According to the latest filing, layoffs will occur in multiple waves throughout the second half of 2026, extending the timeline of workforce reductions well beyond earlier projections.
Under New Jersey’s WARN law, employers with at least 100 workers must provide advance notice of large-scale layoffs and are required to provide severance to affected employees.
Regional impact
Bristol Myers Squibb remains one of the largest employers in the region and a major presence in Mercer County.
The continued workforce reductions reflect broader changes within the pharmaceutical industry, where companies are adjusting operations in response to shifting market conditions, patent expirations, and pricing pressures.
